INHIBITION OF N6-METHYLADENOSINE (m6A) MODIFICATION AS A NOVEL TREATMENT STRATEGY FOR ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL). (October 2022) - Mun, L.; Miano, V.; Webster, N.; Andrews, B.; Han, N.; Burke, A.; Barberi, I.; Turner, S.